<DOC>
	<DOCNO>NCT00892502</DOCNO>
	<brief_summary>The purpose study determine whether treatment Bismuth reduce toxicity chemotherapy radiotherapy patient malignant disease blood .</brief_summary>
	<brief_title>Can Treatment With Bismuth Reduce Toxicity Chemotherapy Radiotherapy ?</brief_title>
	<detailed_description />
	<mesh_term>Multiple Myeloma</mesh_term>
	<mesh_term>Neoplasms</mesh_term>
	<mesh_term>Lymphoma</mesh_term>
	<mesh_term>Hematologic Diseases</mesh_term>
	<mesh_term>Bismuth</mesh_term>
	<criteria>Patients 18 year refer Department Haematology L , Herlev Hospital , view 'cytostatic ' ? treatment radiotherapy haematological malignancy Pregnant woman nurse mother No inform consent patient Known hyper sensitivity bismuth tablet content Severe renal insufficiency creatinin clearance 25 ml/min . Patients receive treatment protection mucous membrane except cryo treatment oral cavity ( lumps ice mouth ) Other experimental treatment within past four week .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>September 2013</verification_date>
	<keyword>haematology</keyword>
	<keyword>haematological</keyword>
	<keyword>hematology</keyword>
	<keyword>hematological</keyword>
	<keyword>malignancy</keyword>
	<keyword>lymphoma</keyword>
	<keyword>myeloma</keyword>
	<keyword>leukemia</keyword>
	<keyword>blood disease</keyword>
	<keyword>malignant</keyword>
	<keyword>bismuth</keyword>
</DOC>